Company Encyclopedia
View More
name
KORU Medical
KRMD.US
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.
1.407 T
KRMD.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking34/171
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-21.71%E
    • Profit Margin-9.50%D
    • Gross Margin60.22%A
  • Growth ScoreB
    • Revenue YoY22.12%A
    • Net Profit YoY68.99%A
    • Total Assets YoY-1.05%D
    • Net Assets YoY-7.15%D
  • Cash ScoreC
    • Cash Flow Margin-1052.49%E
    • OCF YoY22.12%A
  • Operating ScoreA
    • Turnover1.43A
  • Debt ScoreB
    • Gearing Ratio39.25%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    KORU Medical Systems Signs Amended Manufacturing and Supply Agreement with Command Medical Products

    KORU Medical Systems Inc. has signed an Amended and Restated Manufacturing and Supply Agreement with Command Medical Products, effective January 1, 2024. Command will manufacture and supply KORU’s products until December 31, 2026, with automatic renewals. The agreement includes terms on pricing, payment, delivery, and confidentiality. This AI-generated news brief is for informational purposes only and not financial advice.

    Reuters·
    US
    KRMD
    -0.70%
    Reuters·
    US
    KRMD
    -0.70%

    KORU Medical Unveils Positive Study Results for FreedomEDGE Infusion System at 2025 Symposium

    KORU Medical Systems Inc. will present research findings on its FreedomEDGE® Syringe Infusion System at the ESID/EHA/SIOPE Focused Symposium 2025 in Vienna. The study, conducted in nine Danish hospitals, showed high nurse and patient satisfaction, with 91% of nurses finding it easier to use and 73% of patients noting improved comfort. KORU Medical plans to submit a 510(k) filing to the FDA for use with a commercialized oncology drug in late 2025 or early 2026.

    Reuters·
    US
    KRMD
    -0.70%
    Reuters·
    US
    KRMD
    -0.70%

    Repro-Med Systems’ Earnings Call Highlights Growth and Challenges

    Repro-Med Systems, Inc. (KRMD) reported strong Q3 earnings with over $10 million in revenue, marking a 27% year-over-year growth. The core SCIG business grew by 30%, and international revenue surged by 230%. The company raised its full-year revenue guidance to $40.5-$41 million. However, challenges include a 5% decline in domestic revenue, gross margin pressures, and pipeline delays. Despite these, the company remains optimistic about sustained growth and profitability.

    Tip Ranks·
    US
    KRMD
    -0.70%
    Tip Ranks·
    US
    KRMD
    -0.70%

    B. Riley Securities Sticks to Their Buy Rating for REPRO-MED Systems (KRMD)

    B. Riley Securities reiterated a Buy rating for REPRO-MED Systems (KRMD) with a price target of $7.00. Lake Street’s Frank Takkinen also issued a Buy rating, while Piper Sandler maintained a Hold rating.

    Tip Ranks·
    US
    KRMD
    -0.70%
    Tip Ranks·
    US
    KRMD
    -0.70%

    KORU Medical Systems shares are trading higher after the company reported better-than-expected Q3 sales results and raised its FY25 sales guidance above estimates.

    benzinga_article·
    US
    KRMD
    -0.70%
    benzinga_article·
    US
    KRMD
    -0.70%
    © 2025 Longbridge｜Disclaimer